J. Calado

发表

Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis.

D. Le Paslier, D. Paslier, F. Silbermann, 1996, Human molecular genetics.

Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria

J. Calado, K. Soto, C. Clemente, 2004, Human Genetics.

Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease.

C. Aguiar, J. Polónia, P. Monteiro, 2019, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

Effect of empagliflozin beyond glycemic control: Cardiovascular benefit in patients with type 2 diabetes and established cardiovascular disease

C. Aguiar, J. Polónia, P. Monteiro, 2019, Revista Portuguesa de Cardiologia (English Edition).

Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.

R. Santer, J. Calado, 2010, American Society of Nephrology. Clinical Journal.

The Na+‐coupled glucose transporter SGLT2 interacts with its accessory unit MAP17 in vitro and their expressions overlap in the renal proximal tubule

J. Ramalho, I. Aires, F. Nolasco, 2018, FEBS letters.

The Kidney Genetics Clinic: delivering precision medicine for kidney patients

F. Nolasco, J. Calado, R. Lucas, 2021, Portuguese Journal of Nephrology & Hypertension.

Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease

S. Lopes, M. Roxo‐Rosa, F. Nolasco, 2021, International journal of molecular sciences.

Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting.

J. Loeffler, K. Lhotta, F. Gok, 2006, Kidney international.

Unusual adult-onset manifestation of an attenuated Bartter's syndrome type IV renal phenotype caused by a mutation in BSND.

J. Calado, J. Rueff, J. R. Santos, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hypouricaemia and hyperuricosuria in familial renal glucosuria

I. Aires, F. Nolasco, J. Calado, 2013, Clinical kidney journal.

Disruption of Urate Transport in Familial Renal Glucosuria and Report on SGLT2 Expression in Normal and Pathological Kidney

I. Aires, F. Nolasco, J. Calado, 2013 .

Effect of kidney disease on glucose handling (including genetic defects).

R. Santer, J. Calado, J. Rueff, 2011, Kidney international. Supplement.

It's an anti-hyperglycaemic… It's a diuretic… It's SGLT2 inhibition! É um anti-hiperglicémico... É um diurético... É a inibição SGLT2!

I. Aires, J. Calado, 2013 .

It ' s an anti-hyperglycaemic ... It ' s a diuretic ... It ' s SGLT 2 inhibition !

J. Calado, 2013 .

Cysteine as a Multifaceted Player in Kidney, the Cysteine-Related Thiolome and Its Implications for Precision Medicine

J. B. Vicente, J. Serpa, Patrícia Branco, 2022, Molecules.

Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations

G. Cavalleri, J. Divers, F. Scolari, 2020, Kidney international reports.

A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis.

J. Weissenbach, R. Heilig, F. Silbermann, 1997, Human molecular genetics.

Portuguese consensus document statement in diagnostic and management of atypical hemolytic uremic syndrome

B. Faria, J. Calado, F. Carvalho, 2018 .

BI-10773, a sodium-glucose cotransporter 2 inhibitor for the potential oral treatment of type 2 diabetes mellitus.

I. Aires, J. Calado, 2010, Current opinion in investigational drugs.

Familial juvenile nephronophthisis

C. Antignac, S. Saunier, M. Gubler, 1998, Journal of Molecular Medicine.

Characterization of the NPHP1 locus: mutational mechanism involved in deletions in familial juvenile nephronophthisis.

J. Weissenbach, R. Heilig, F. Silbermann, 2000, American journal of human genetics.

Not the usual suspect

F. Nolasco, J. Calado, Filipa Cardoso, 2020, Portuguese Journal of Nephrology & Hypertension.

Twenty-one additional cases of familial renal glucosuria: absence of genetic heterogeneity, high prevalence of private mutations and further evidence of volume depletion.

Yves Sznajer, Ana Rita, V. Tasic, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2.

D. Bichet, R. Santer, J. Calado, 2017, Journal of the American Society of Nephrology : JASN.

Anti-Phospholipase A2 Receptor Antibodies in the Diagnosis of Idiopathic Membranous Nephropathy

Carina Ferreira, F. Nolasco, J. Calado, 2015 .

Anti-Phospholipase A2 Receptor Antibodies in the Diagnosis of Idiopathic Membranous Nephropathy

Carina Ferreira, F. Nolasco, J. Calado, 2015 .

Nephrotic syndrome in a patient with metastatic melanoma: beyond the obvious

F. Nolasco, J. Calado, H. Viana, 2020 .

Atypical adult-onset methylmalonic acidemia and homocystinuria presenting as hemolytic uremic syndrome

L. Vilarinho, F. Nolasco, J. Calado, 2018, CEN Case Reports.

An Atypical Presentation of Thrombotic Microangiopathy After Lung Transplant: A Case Report.

I. Aires, F. Nolasco, J. Calado, 2019, Transplantation proceedings.